基于影像组学列线图预测SARS-CoV-2所致2019新型冠状病毒肺炎
本研究回顾性开发并验证了基于CT肺实质窗影像组学特征联合临床影像征象的列线图模型,用于预测COVID-19肺炎。训练集136例COVID-19与103例其他病毒性肺炎,验证集90例(56例COVID-19、34例其他病毒性肺炎)。模型在训练集AUC 0.959(95%CI 0.933-0.985)、验证集AUC 0.955(95%CI 0.899-0.995),校准良好,决策曲线显示临床有用。
要点
- 影像组学列线图在验证集预测COVID-19肺炎的AUC为0.955(95%CI 0.899-0.995)。
- 中央或外周分布、最大病灶范围>10 cm、累及全部五个肺叶、肺门及纵隔淋巴结增大、无胸腔积液与COVID-19风险增加相关。
- 影像组学模型预测效能优于临床模型。
关键影像表现/征象
- 中央或外周分布、最大病灶范围>10 cm、累及全部五个肺叶、肺门及纵隔淋巴结增大、无胸腔积液与COVID-19肺炎风险增加相关。
诊断标准与关键数值
- 影像组学标签由3个所选特征组成,在训练集和验证集中均与COVID-19肺炎显著相关(p < 0.05)。
- 多变量逻辑回归模型纳入影像组学标签、分布、最大病灶、肺门及纵隔淋巴结增大和胸腔积液。
- 列线图在训练集AUC 0.959(95%CI 0.933-0.985),验证集AUC 0.955(95%CI 0.899-0.995),校准良好。
临床应用与阅片要点
- 作者认为该影像组学模型对预测COVID-19肺炎有良好性能,可能有助于临床决策。
- 影像组学模型预测效能优于临床模型。
- 决策曲线分析表明影像组学列线图具有临床有用性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To develop and validate a radiomics model for predicting 2019 novel coronavirus (COVID-19) pneumonia.
METHODS: For this retrospective study, a radiomics model was developed on the basis of a training set consisting of 136 patients with COVID-19 pneumonia and 103 patients with other types of viral pneumonia. Radiomics features were extracted from the lung parenchyma window. A radiomics signature was built on the basis of reproducible features, using the least absolute shrinkage and selection operator method (LASSO). Multivariable logistic regression model was adopted to establish a radiomics nomogram. Nomogram performance was determined by its discrimination, calibration, and clinical usefulness. The model was validated in 90 consecutive patients, of which 56 patients had COVID-19 pneumonia and 34 patients had other types of viral pneumonia.
RESULTS: The radiomics signature, consisting of 3 selected features, was significantly associated with COVID-19 pneumonia (p < 0.05) in both training and validation sets. The multivariable logistic regression model included the radiomics signature and distribution; maximum lesion, hilar, and mediastinal lymph node enlargement; and pleural effusion. The individualized prediction nomogram showed good discrimination in the training sample (area under the receiver operating characteristic curve [AUC], 0.959; 95% confidence interval [CI], 0.933-0.985) and in the validation sample (AUC, 0.955; 95% CI, 0.899-0.995) and good calibration. The mixed model achieved better predictive efficacy than the clinical model. Decision curve analysis demonstrated that the radiomics nomogram was clinically useful.
CONCLUSIONS: The radiomics model derived has good performance for predicting COVID-19 pneumonia and may help in clinical decision-making.
KEY POINTS: • A radiomics model showed good performance for prediction 2019 novel coronavirus pneumonia and favorable discrimination for other types of pneumonia on CT images. • A central or peripheral distribution, a maximum lesion range > 10 cm, the involvement of all five lobes, hilar and mediastinal lymph node enlargement, and no pleural effusion is associated with an increased risk of 2019 novel coronavirus pneumonia. • A radiomics model was superior to a clinical model in predicting 2019 novel coronavirus pneumonia.
引用
- Fang X, Li X, Bian Y, et al. Radiomics nomogram for the prediction of 2019 novel coronavirus pneumonia caused by SARS-CoV-2. Eur Radiol. 2020. PMID: 32621237. doi:10.1007/s00330-020-07032-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。